The Valvular Diseases Learning Pathway at ACC.27-WCC arrives at a pivotal moment for the field, anchored by the anticipated release of the new ACC/AHA Valvular Heart Disease Guidelines. The pathway is built to give clinicians practical tools for translating the guidelines, new trial data and expert consensus into real-world patient care. The pathway focuses on the gaps that remain between what the guidelines recommend and how care is delivered.
Aortic valve disease receives particular attention this year, from contemporary approaches to aortic regurgitation to the lifetime management questions surrounding aortic stenosis, including the evolving role of artificial intelligence in diagnosis and timing of intervention. Sessions also focus on building and sustaining effective multidisciplinary heart teams, the clinical collaboration required for complex valve interventions, and the financial and operational realities of running a structural heart program.
Sessions You Won't Want to Miss:
Update your ACC.org communication and privacy settings to receive Annual Scientific Session news and announcements.
Manage Communication Preferences© 2025 American College of Cardiology Foundation. Visit ACC.org